Vigil Neuroscience Inc VIGL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
3.66UNCH (UNCH)
Volume
682
Close
3.66quote price arrow up+0.01 (+0.27%)
Volume
54,456
52 week range
2.50 - 11.11
Loading...
  • Open3.67
  • Day High3.78
  • Day Low3.59
  • Prev Close3.65
  • 52 Week High11.11
  • 52 Week High Date06/20/23
  • 52 Week Low2.50
  • 52 Week Low Date04/26/24

Key Stats

  • Market Cap137.559M
  • Shares Out37.58M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta1.88
  • YTD % Change8.28

KEY STATS

  • Open3.67
  • Day High3.78
  • Day Low3.59
  • Prev Close3.65
  • 52 Week High11.11
  • 52 Week High Date06/20/23
  • 52 Week Low2.50
  • 52 Week Low Date04/26/24
  • Market Cap137.559M
  • Shares Out37.58M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta1.88
  • YTD % Change8.28

RATIOS/PROFITABILITY

  • EPS (TTM)-2.12
  • P/E (TTM)-1.73
  • Fwd P/E (NTM)-1.77
  • EBITDA (TTM)-89.059M
  • ROE (TTM)-60.18%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vigil Neuroscience Inc

 

Profile

MORE
Vigil Neuroscience, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in its efforts to develop precision-based therapies to improve the lives of patients and their families. Its lead clinical...
Bruce Booth Ph.D.
Independent Chairman of the Board
Ivana Magovcevic-liebisch J.D., Ph.D.
President, Chief Executive Officer, Director
Jennifer Ziolkowski CPA
Chief Financial Officer
Christopher Verni J.D.
General Counsel
Address
100 Forge Road, Suite 700
Watertown, MA
02472
United States

Top Peers

SYMBOLLASTCHG%CHG
RZLT
Rezolute Inc
2.68-0.17-5.96%
ACET
Adicet Bio Inc
1.33-0.11-7.64%
NVCT
Nuvectis Pharma Inc
6.77+0.42+6.61%
VTGN
Vistagen Therapeutics Inc
4.52-0.01-0.22%
VOR
Vor Biopharma Inc
1.68-0.02-1.18%